Condition
Basal Cell Carcinoma of Skin clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Basal Cell Carcinoma of Skin clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Denmark (1), Germany (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Basal Cell Carcinoma of Skin clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Multimodal Imaging Usability in Basal Cell Carcinoma | — | Copenhagen, Denmark | Recruiting | Sep 3, 2026 |
| Two-photon microscopy on skin biopsies to help diagnose skin lesions | — | Victor, New York | Recruiting | Aug 19, 2026 |
| Machine learning assessment of two-photon microscopy images from skin biopsies | — | Victor, New York | Recruiting | Jul 6, 2026 |
| First-in-human test of KUP-101A in selected advanced skin cancers | Phase 1 | Munich, Bavaria and 2 other locations | Recruiting | May 20, 2026 |
| Real-world use of LC-OCT to help diagnose basal cell carcinoma | — | Maastricht, Limburg | Recruiting | Mar 30, 2026 |
All recruiting trials (5)
-
Multimodal Imaging Usability in Basal Cell Carcinoma
We’re testing how easy and quick three non-invasive imaging tools are for adults with basal cell carcinoma to use during a single visit.
-
Two-photon microscopy on skin biopsies to help diagnose skin lesions
This study tests whether images from two-photon fluorescence microscopy of dermatology biopsies can match the diagnosis determined by standard histology.
-
Machine learning assessment of two-photon microscopy images from skin biopsies
A machine learning model is tested on two-photon microscopy images of skin biopsy samples taken in clinic to see if it can correctly predict basal cell carcinoma, squamous cell carcinoma, or non-cancer compared with standard histology.
-
First-in-human test of KUP-101A in selected advanced skin cancers
This early study tests KUP-101A to see if it's safe and tolerable and to gather initial clues about its activity in patients with advanced skin cancers.
-
Real-world use of LC-OCT to help diagnose basal cell carcinoma
This study tests how well LC-OCT works in everyday dermatology practice to help diagnose basal cell carcinoma without always needing a biopsy.
Related topics
Quick answers
How many Basal Cell Carcinoma of Skin clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Denmark (1 trial), Germany (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.